Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.

By Y. Todo, H. Kato, M. Kaneuchi, H. Watari, M. Takeda, N. Sakuragi. The Lancet, 2010

713 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015, methodology): “On the basis of these findings, the authors concluded that the presence of LND and increased number of nodes dissected predicted for improved OS and uterine-specific survival in women with adenocarcinoma of the endometrium.”
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer (2015, methodology): “This was confirmed by the SEPAL trial in a series of intermediate- or high-risk patients with pelvic lymphadenectomy with or without para-aortic LND.(100) Patients who underwent para-aortic lymphadenectomy had a superior survival compared with those who did not.”
Erratum to: Endometrial Cancer (2017, background): “submitted to combined pelvic and para-aortic lymphadenectomy (Todo et al. 2010).”